Naxitamab Biosimilar - Research Grade

• Background:

  Uses the same sequence as the therapeutic antibody Naxitamab

• Specifications:

  Detects human Ganglioside GD2

• Species Reactivity:

  Human

• Target:

  Ganglioside GD2

• Applications:

  Functional Assays

• Purification Method:

  This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

• Concentration:

  5mg/mL

• Endotoxin:

  <1EU/mg Determined by LAL gel clotting assay

• Purity:

  ≥95% monomer by analytical SEC, >95% by SDS Page

• Buffer:

  ICH3002

• Shipping Conditions:

  Blue ice

• Storage Conditions:

  This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

• Formulation:

  Sterile, preservative-free, solution in PBS. BSA and Azide free.

• Applications Notes:

  This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.